Bio-Techne (TECH) Tops Q4 EPS by 17c

Bio-Techne (NASDAQ: TECH) reported Q4 EPS of $1.87, $0.17 better than the analyst estimate of $1.70. Revenue for the quarter came in at $259 million versus the consensus estimate of $244.62 million.

For earnings history and earnings-related data on Bio-Techne (TECH) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Bio-Techne (TECH) Reports In-Line Q4 EPS
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49